JPRN-UMIN000018932
Recruiting
未知
Evaluation of diagnostic test for the superficial bladder cancer based intravesical instillation of pirarubicin (THP) prior to transurethral resection (TUR) - The significance of intravesical instillation of pirarubicin (THP) for preoperative superficial bladder cancer
Dokkyo Medical University, Department of Urology0 sites30 target enrollmentSeptember 7, 2015
ConditionsSuperficial bladder cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Superficial bladder cancer
- Sponsor
- Dokkyo Medical University, Department of Urology
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •progressive cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigation and validation of the diagnostic performance of new biomarker candidates for (I) the early detection of an infectious origin of neutropenic fever and for the prediction of (II) an infection of patients after apoplectic stroke and the progression of (III) a nosocomial infection or (IV) a community acquired pneunomia to a severe sepsis/ septic shockA41.9Sepsis, unspecifiedDRKS00004159Institut für Klinische Chemie und Laboratoriumsdiagnostik / Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen1,018
Recruiting
Not Applicable
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).ACTRN12609000057280Health Research Council of New Zealand2,000
Recruiting
Not Applicable
A study on the assessment of diagnostic and therapeutic efficacy using contrast-enhanced FDG-PET/CT for cardiac sarcoidosisCardiac sarcoidosisJPRN-UMIN000046704Ehime university50
Recruiting
Not Applicable
Evaluation of the accuracy of diagnosis by simple scoring system for SNADETJPRN-UMIN000047039TT Medical Center Tokyo1,000
Completed
Phase 1
Pilot trial assessment of the diagnostic value of Cu64 SAR-Bombesin PET/CT imaging for staging of ER/PR + HER2- breast cancer patients with metastatic disease in comparison with conventional imaging (CT, bone scan and 18F-FDG PET/CT)Hormone Positive Metastatic Breast CancerCancer - BreastACTRN12619001383156St Vincent's Hospital7